3.26.1 html 292 321 1 true 127 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://yd-biopharma.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://yd-biopharma.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://yd-biopharma.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations and Comprehensive Income/(Loss) Sheet http://yd-biopharma.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations and Comprehensive Income/(Loss) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Changes in Shareholders’ Equity (Deficits) Sheet http://yd-biopharma.com/role/ShareholdersEquityType2or3 Consolidated Statements of Changes in Shareholders’ Equity (Deficits) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://yd-biopharma.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Organization Sheet http://yd-biopharma.com/role/Organization Organization Notes 7 false false R8.htm 007 - Disclosure - Going Concern Sheet http://yd-biopharma.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://yd-biopharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Accounts Receivable Sheet http://yd-biopharma.com/role/AccountsReceivable Accounts Receivable Notes 10 false false R11.htm 010 - Disclosure - Inventories Sheet http://yd-biopharma.com/role/Inventories Inventories Notes 11 false false R12.htm 011 - Disclosure - Prepaid Expenses and Other Current Assets Sheet http://yd-biopharma.com/role/PrepaidExpensesandOtherCurrentAssets Prepaid Expenses and Other Current Assets Notes 12 false false R13.htm 012 - Disclosure - Property, Plant and Equipment, Net Sheet http://yd-biopharma.com/role/PropertyPlantandEquipmentNet Property, Plant and Equipment, Net Notes 13 false false R14.htm 013 - Disclosure - Intangible Assets Sheet http://yd-biopharma.com/role/IntangibleAssets Intangible Assets Notes 14 false false R15.htm 014 - Disclosure - Deferred Offering Costs Sheet http://yd-biopharma.com/role/DeferredOfferingCosts Deferred Offering Costs Notes 15 false false R16.htm 015 - Disclosure - Prepaid Expenses, Non-Current Sheet http://yd-biopharma.com/role/PrepaidExpensesNonCurrent Prepaid Expenses, Non-Current Notes 16 false false R17.htm 016 - Disclosure - Leases Sheet http://yd-biopharma.com/role/Leases Leases Notes 17 false false R18.htm 017 - Disclosure - Accounts Payable Sheet http://yd-biopharma.com/role/AccountsPayable Accounts Payable Notes 18 false false R19.htm 018 - Disclosure - Accrued Expenses and Other Liabilities Sheet http://yd-biopharma.com/role/AccruedExpensesandOtherLiabilities Accrued Expenses and Other Liabilities Notes 19 false false R20.htm 019 - Disclosure - Warrants Sheet http://yd-biopharma.com/role/Warrants Warrants Notes 20 false false R21.htm 020 - Disclosure - Shareholder's Deficit Sheet http://yd-biopharma.com/role/ShareholdersDeficit Shareholder's Deficit Notes 21 false false R22.htm 021 - Disclosure - Fair Value Measurements Sheet http://yd-biopharma.com/role/FairValueMeasurements Fair Value Measurements Notes 22 false false R23.htm 022 - Disclosure - Revenue Sheet http://yd-biopharma.com/role/Revenue Revenue Notes 23 false false R24.htm 023 - Disclosure - Research and Development Expenses Sheet http://yd-biopharma.com/role/ResearchandDevelopmentExpenses Research and Development Expenses Notes 24 false false R25.htm 024 - Disclosure - Income Taxes Sheet http://yd-biopharma.com/role/IncomeTaxes Income Taxes Notes 25 false false R26.htm 025 - Disclosure - Commitments and Contingencies Sheet http://yd-biopharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 26 false false R27.htm 026 - Disclosure - Related Party Transactions Sheet http://yd-biopharma.com/role/RelatedPartyTransactions Related Party Transactions Notes 27 false false R28.htm 027 - Disclosure - Segment Reporting Sheet http://yd-biopharma.com/role/SegmentReporting Segment Reporting Notes 28 false false R29.htm 028 - Disclosure - Subsequent Events Sheet http://yd-biopharma.com/role/SubsequentEvents Subsequent Events Notes 29 false false R30.htm 996000 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://yd-biopharma.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://yd-biopharma.com/role/SummaryofSignificantAccountingPolicies 30 false false R31.htm 996001 - Disclosure - Organization (Tables) Sheet http://yd-biopharma.com/role/OrganizationTables Organization (Tables) Tables http://yd-biopharma.com/role/Organization 31 false false R32.htm 996002 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://yd-biopharma.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://yd-biopharma.com/role/SummaryofSignificantAccountingPolicies 32 false false R33.htm 996003 - Disclosure - Accounts Receivable (Tables) Sheet http://yd-biopharma.com/role/AccountsReceivableTables Accounts Receivable (Tables) Tables http://yd-biopharma.com/role/AccountsReceivable 33 false false R34.htm 996004 - Disclosure - Inventories (Tables) Sheet http://yd-biopharma.com/role/InventoriesTables Inventories (Tables) Tables http://yd-biopharma.com/role/Inventories 34 false false R35.htm 996005 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) Sheet http://yd-biopharma.com/role/PrepaidExpensesandOtherCurrentAssetsTables Prepaid Expenses and Other Current Assets (Tables) Tables http://yd-biopharma.com/role/PrepaidExpensesandOtherCurrentAssets 35 false false R36.htm 996006 - Disclosure - Property, Plant and Equipment, Net (Tables) Sheet http://yd-biopharma.com/role/PropertyPlantandEquipmentNetTables Property, Plant and Equipment, Net (Tables) Tables http://yd-biopharma.com/role/PropertyPlantandEquipmentNet 36 false false R37.htm 996007 - Disclosure - Intangible Assets (Tables) Sheet http://yd-biopharma.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://yd-biopharma.com/role/IntangibleAssets 37 false false R38.htm 996008 - Disclosure - Leases (Tables) Sheet http://yd-biopharma.com/role/LeasesTables Leases (Tables) Tables http://yd-biopharma.com/role/Leases 38 false false R39.htm 996009 - Disclosure - Accrued Expenses and Other Liabilities (Tables) Sheet http://yd-biopharma.com/role/AccruedExpensesandOtherLiabilitiesTables Accrued Expenses and Other Liabilities (Tables) Tables http://yd-biopharma.com/role/AccruedExpensesandOtherLiabilities 39 false false R40.htm 996010 - Disclosure - Fair Value Measurements (Tables) Sheet http://yd-biopharma.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://yd-biopharma.com/role/FairValueMeasurements 40 false false R41.htm 996011 - Disclosure - Revenue (Tables) Sheet http://yd-biopharma.com/role/RevenueTables Revenue (Tables) Tables http://yd-biopharma.com/role/Revenue 41 false false R42.htm 996012 - Disclosure - Income Taxes (Tables) Sheet http://yd-biopharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://yd-biopharma.com/role/IncomeTaxes 42 false false R43.htm 996013 - Disclosure - Related Party Transactions (Tables) Sheet http://yd-biopharma.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://yd-biopharma.com/role/RelatedPartyTransactions 43 false false R44.htm 996014 - Disclosure - Segment Reporting (Tables) Sheet http://yd-biopharma.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://yd-biopharma.com/role/SegmentReporting 44 false false R45.htm 996015 - Disclosure - Organization (Details) Sheet http://yd-biopharma.com/role/OrganizationDetails Organization (Details) Details http://yd-biopharma.com/role/OrganizationTables 45 false false R46.htm 996016 - Disclosure - Organization - Schedule of Direct and Indirect Interests in Subsidiaries (Details) Sheet http://yd-biopharma.com/role/ScheduleofDirectandIndirectInterestsinSubsidiariesTable Organization - Schedule of Direct and Indirect Interests in Subsidiaries (Details) Details 46 false false R47.htm 996017 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://yd-biopharma.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://yd-biopharma.com/role/SummaryofSignificantAccountingPoliciesTables 47 false false R48.htm 996018 - Disclosure - Summary of Significant Accounting Policies - Schedule of Amortization Periods for Intangible Assets (Details) Sheet http://yd-biopharma.com/role/ScheduleofAmortizationPeriodsforIntangibleAssetsTable Summary of Significant Accounting Policies - Schedule of Amortization Periods for Intangible Assets (Details) Details 48 false false R49.htm 996019 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Revenue from Lease (Details) Sheet http://yd-biopharma.com/role/ScheduleofDeferredRevenuefromLeaseTable Summary of Significant Accounting Policies - Schedule of Deferred Revenue from Lease (Details) Details 49 false false R50.htm 996020 - Disclosure - Summary of Significant Accounting Policies - Schedule of Exchange Rates (Details) Sheet http://yd-biopharma.com/role/ScheduleofExchangeRatesTable Summary of Significant Accounting Policies - Schedule of Exchange Rates (Details) Details 50 false false R51.htm 996021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Concentration of Risks (Details) Sheet http://yd-biopharma.com/role/ScheduleofConcentrationofRisksTable Summary of Significant Accounting Policies - Schedule of Concentration of Risks (Details) Details 51 false false R52.htm 996022 - Disclosure - Accounts Receivable (Details) Sheet http://yd-biopharma.com/role/AccountsReceivableDetails Accounts Receivable (Details) Details http://yd-biopharma.com/role/AccountsReceivableTables 52 false false R53.htm 996023 - Disclosure - Accounts Receivable - Schedule of Accounts Receivable, Net (Details) Sheet http://yd-biopharma.com/role/ScheduleofAccountsReceivableNetTable Accounts Receivable - Schedule of Accounts Receivable, Net (Details) Details 53 false false R54.htm 996024 - Disclosure - Accounts Receivable - Schedule of Expected Credit Loss Provision (Details) Sheet http://yd-biopharma.com/role/ScheduleofExpectedCreditLossProvisionTable Accounts Receivable - Schedule of Expected Credit Loss Provision (Details) Details 54 false false R55.htm 996025 - Disclosure - Inventories (Details) Sheet http://yd-biopharma.com/role/InventoriesDetails Inventories (Details) Details http://yd-biopharma.com/role/InventoriesTables 55 false false R56.htm 996026 - Disclosure - Inventories - Schedule of Inventories, Net (Details) Sheet http://yd-biopharma.com/role/ScheduleofInventoriesNetTable Inventories - Schedule of Inventories, Net (Details) Details 56 false false R57.htm 996027 - Disclosure - Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Details) Sheet http://yd-biopharma.com/role/ScheduleofPrepaidExpensesandOtherCurrentAssetsTable Prepaid Expenses and Other Current Assets - Schedule of Prepaid Expenses and Other Current Assets (Details) Details 57 false false R58.htm 996028 - Disclosure - Property, Plant and Equipment, Net (Details) Sheet http://yd-biopharma.com/role/PropertyPlantandEquipmentNetDetails Property, Plant and Equipment, Net (Details) Details http://yd-biopharma.com/role/PropertyPlantandEquipmentNetTables 58 false false R59.htm 996029 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) Sheet http://yd-biopharma.com/role/ScheduleofPropertyPlantandEquipmentTable Property, Plant and Equipment, Net - Schedule of Property, Plant and Equipment (Details) Details 59 false false R60.htm 996030 - Disclosure - Intangible Assets (Details) Sheet http://yd-biopharma.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://yd-biopharma.com/role/IntangibleAssetsTables 60 false false R61.htm 996031 - Disclosure - Intangible Assets - Schedule of Following Amounts in Accordance with the Following Milestones (Details) Sheet http://yd-biopharma.com/role/ScheduleofFollowingAmountsinAccordancewiththeFollowingMilestonesTable Intangible Assets - Schedule of Following Amounts in Accordance with the Following Milestones (Details) Details 61 false false R62.htm 996032 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details) Sheet http://yd-biopharma.com/role/ScheduleofIntangibleAssetsTable Intangible Assets - Schedule of Intangible Assets (Details) Details 62 false false R63.htm 996033 - Disclosure - Intangible Assets - Schedule of Estimated Amortization (Details) Sheet http://yd-biopharma.com/role/ScheduleofEstimatedAmortizationTable Intangible Assets - Schedule of Estimated Amortization (Details) Details 63 false false R64.htm 996034 - Disclosure - Prepaid Expenses, Non-Current (Details) Sheet http://yd-biopharma.com/role/PrepaidExpensesNonCurrentDetails Prepaid Expenses, Non-Current (Details) Details http://yd-biopharma.com/role/PrepaidExpensesNonCurrent 64 false false R65.htm 996035 - Disclosure - Leases (Details) Sheet http://yd-biopharma.com/role/LeasesDetails Leases (Details) Details http://yd-biopharma.com/role/LeasesTables 65 false false R66.htm 996036 - Disclosure - Leases - Schedule of Consolidated Balance Sheets (Details) Sheet http://yd-biopharma.com/role/ScheduleofConsolidatedBalanceSheetsTable Leases - Schedule of Consolidated Balance Sheets (Details) Details 66 false false R67.htm 996037 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details) Sheet http://yd-biopharma.com/role/ScheduleofMaturitiesofLeaseLiabilitiesTable Leases - Schedule of Maturities of Lease Liabilities (Details) Details 67 false false R68.htm 996038 - Disclosure - Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Details) Sheet http://yd-biopharma.com/role/ScheduleofAccruedExpensesandOtherLiabilitiesTable Accrued Expenses and Other Liabilities - Schedule of Accrued Expenses and Other Liabilities (Details) Details 68 false false R69.htm 996039 - Disclosure - Warrants (Details) Sheet http://yd-biopharma.com/role/WarrantsDetails Warrants (Details) Details http://yd-biopharma.com/role/Warrants 69 false false R70.htm 996040 - Disclosure - Shareholder's Deficit (Details) Sheet http://yd-biopharma.com/role/ShareholdersDeficitDetails Shareholder's Deficit (Details) Details http://yd-biopharma.com/role/ShareholdersDeficit 70 false false R71.htm 996041 - Disclosure - Fair Value Measurements (Details) Sheet http://yd-biopharma.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://yd-biopharma.com/role/FairValueMeasurementsTables 71 false false R72.htm 996042 - Disclosure - Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Recurring Basis (Details) Sheet http://yd-biopharma.com/role/ScheduleofFinancialAssetsMeasuredatFairValueonRecurringBasisTable Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Recurring Basis (Details) Details 72 false false R73.htm 996043 - Disclosure - Fair Value Measurements - Changes in Fair Value of Warrant Liabilities (Details) Sheet http://yd-biopharma.com/role/ChangesinFairValueofWarrantLiabilitiesTable Fair Value Measurements - Changes in Fair Value of Warrant Liabilities (Details) Details 73 false false R74.htm 996044 - Disclosure - Revenue - Schedule of Revenue (Details) Sheet http://yd-biopharma.com/role/ScheduleofRevenueTable Revenue - Schedule of Revenue (Details) Details 74 false false R75.htm 996045 - Disclosure - Revenue - Schedule of Net Revenues by Geographic Area (Details) Sheet http://yd-biopharma.com/role/ScheduleofNetRevenuesbyGeographicAreaTable Revenue - Schedule of Net Revenues by Geographic Area (Details) Details 75 false false R76.htm 996046 - Disclosure - Research and Development Expenses (Details) Sheet http://yd-biopharma.com/role/ResearchandDevelopmentExpensesDetails Research and Development Expenses (Details) Details http://yd-biopharma.com/role/ResearchandDevelopmentExpenses 76 false false R77.htm 996047 - Disclosure - Income Taxes (Details) Sheet http://yd-biopharma.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://yd-biopharma.com/role/IncomeTaxesTables 77 false false R78.htm 996048 - Disclosure - Income Taxes - Schedule of Components of Provision for Income Taxes (Benefits) (Details) Sheet http://yd-biopharma.com/role/ScheduleofComponentsofProvisionforIncomeTaxesBenefitsTable Income Taxes - Schedule of Components of Provision for Income Taxes (Benefits) (Details) Details 78 false false R79.htm 996049 - Disclosure - Income Taxes - Schedule of Reconciliation of Differences Between Income Tax Rate Profits and Income Tax (Benefits) Expenses (Details) Sheet http://yd-biopharma.com/role/ScheduleofReconciliationofDifferencesBetweenIncomeTaxRateProfitsandIncomeTaxBenefitsExpensesTable Income Taxes - Schedule of Reconciliation of Differences Between Income Tax Rate Profits and Income Tax (Benefits) Expenses (Details) Details 79 false false R80.htm 996050 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Liabilities) (Details) Sheet http://yd-biopharma.com/role/ScheduleofDeferredTaxAssetsLiabilitiesTable Income Taxes - Schedule of Deferred Tax Assets (Liabilities) (Details) Details 80 false false R81.htm 996051 - Disclosure - Commitments and Contingencies (Details) Sheet http://yd-biopharma.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://yd-biopharma.com/role/CommitmentsandContingencies 81 false false R82.htm 996052 - Disclosure - Related Party Transactions (Details) Sheet http://yd-biopharma.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://yd-biopharma.com/role/RelatedPartyTransactionsTables 82 false false R83.htm 996053 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) Sheet http://yd-biopharma.com/role/ScheduleofRelatedPartyTransactionsTable Related Party Transactions - Schedule of Related Party Transactions (Details) Details 83 false false R84.htm 996054 - Disclosure - Segment Reporting (Details) Sheet http://yd-biopharma.com/role/SegmentReportingDetails Segment Reporting (Details) Details http://yd-biopharma.com/role/SegmentReportingTables 84 false false R85.htm 996055 - Disclosure - Segment Reporting - Schedule of Segment Information (Details) Sheet http://yd-biopharma.com/role/ScheduleofSegmentInformationTable Segment Reporting - Schedule of Segment Information (Details) Details 85 false false R86.htm 996056 - Disclosure - Subsequent Events (Details) Sheet http://yd-biopharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://yd-biopharma.com/role/SubsequentEvents 86 false false All Reports Book All Reports ea0291209-posam1_ydbio.htm ydesw-20251231.xsd ydesw-20251231_cal.xml ydesw-20251231_def.xml ydesw-20251231_lab.xml ydesw-20251231_pre.xml ea029120901_img1.jpg ea029120901_img2.jpg ea029120901_img3.jpg ea029120901_img4.jpg ea029120901_img5.jpg ea029120901_img6.jpg ea029120901_img7.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 true true